News related to Avastin (Bevacizumab) and/or conditions it is approved for
New study data find Avastin® (bevacizumab) and cetuximab help patients with KRAS wild-type advanced bowel cancer live similar length of time
Source: Colorectal Cancer News From Medical News Today [2014.06.04]
CALGB 80405, a large, independent, phase III study, designed to assess the superiority in overall survival (OS) of cetuximab over Avastin® (bevacizumab) when combined with either FOLFOX or...
Avastin May Help Fight Early Breast Cancer
Source: MedicineNet capecitabine Specialty [2012.01.26]
Title: Avastin May Help Fight Early Breast Cancer
Category: Health News
Created: 1/26/2012 11:00:00 AM
Last Editorial Review: 1/26/2012 12:00:00 AM
In KRAS wild-type MCRC, equivalent survival offered by cetuximab or bevacizumab with combi chemo
Source: Colorectal Cancer News From Medical News Today [2014.07.01]
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress...